Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis

Area of Science:

• Immunology
• Neuroimmunology
• Cellular Immunology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
• The role of specific cytokine-secreting immune cells in MS pathogenesis is not fully understood.
• Previous studies suggest altered cytokine profiles in MS patients.

Purpose of the Study:

• To quantify peripheral blood cells secreting Interleukin 4 (IL-4) and Interferon gamma (IFN gamma) in multiple sclerosis (MS) patients.
• To compare these cell counts between patients with relapsing-remitting MS during exacerbations, patients with chronic progressive MS (CPMS), and healthy controls.
• To investigate the in vitro response of these cells to myelin basic protein (MBP) stimulation.

Main Methods:

• Enumeration of IL-4 and IFN gamma-secreting peripheral blood cells using immunospot assay.
• Comparison of cell counts across three groups: MS exacerbation (n=13), CPMS (n=24), and controls (n=20).
• In vitro stimulation with MBP to assess cellular reactivity.

Main Results:

• Spontaneously secreted IFN gamma-secreting cells were significantly higher in MS patients during exacerbations compared to controls and CPMS patients.
• IL-4-secreting cell numbers were significantly elevated in both MS groups compared to controls.
• MBP stimulation led to a greater increase in IFN gamma-secreting cells in acutely exacerbating MS patients compared to controls.

Conclusions:

• Increased numbers of IFN gamma-secreting cells correlate with MS exacerbations, supporting prior findings of elevated IFN gamma.
• The role of increased IL-4-secreting cells in MS requires further investigation, potentially involving immune regulation.
• Results provide evidence for T-cell reactivity to MBP in MS, though its pathogenic significance remains unclear.